STEM CELLS IN THE TREATMENT OF TYPE 1 DIABETES MELLITUS

Abstract

Type 1 Diabetes Mellitus is a chronic, autoimmune disease caused by the destruction of beta cells in the pancreas, which compromises insulin production and leads to increased blood glucose levels. Although insulin treatment helps control blood glucose levels, it does not restore pancreatic function. Stem cell therapy has emerged as a promising alternative due to its ability to regenerate tissue and restore natural insulin production. Despite advances, there are still challenges related to the safety and efficacy of the treatment, but clinical results show improvements in glycemic control and quality of life for patients. Given the above, the study's general objective is to evaluate the efficacy of stem cell therapy in patients with Type 1 Diabetes Mellitus. This work is characterized as a qualitative bibliographic study with a descriptive and exploratory approach. The research was conducted by surveying scientific productions available in national and international databases, such as Scielo, PubMed, Lilacs, Bireme and Google Scholar. It is understood that the use of stem cells in the treatment of Type 1 Diabetes Mellitus has the potential to transform the way the disease is currently treated. Although it is still in the process of consolidation, this strategy represents real hope for thousands of people who live daily with the challenges of this chronic condition.